[O2-4] SARS2-5

[O2-4-18] Characterizing the fusogenicity of SARS-CoV-2 variants via Spike protein-mediated membrane fusion assay

*Hesham Nasser¹, Rigel Suzuki², Mai Kishimoto³, Ryo Shimizu¹, the Genotype to Phenotype Japan (G2P-Japan), Akatsuki Saito⁴, Kei Sato⁵, Keita Matsuno³, Takasuke Fukuhara², Terumasa Ikeda¹ (1. Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 2. Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 3. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, 4. Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan, 5. Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)